Defining the better algorithm for the accurate identification of HPV status among oropharyngeal squamous-cell carcinoma. Results from a pilot study WCRJ 2015; 2 (1): e497
Selected Pharmacogenetic panel test for toxicity prevention of drug-drug interactions between Highly Active Antiretroviral Therapy (HAART) and antiblastic chemotherapy WCRJ 2015; 2 (1): e492
Hepatocellular carcinoma: an overview of clinico-pathological and molecular perspectives WCRJ 2015; 2 (1): e485
Pharmacogenomics of Cytochrome P450 Family enzymes: implications for drug-drug interaction in anticancer therapy WCRJ 2015; 2 (1): e483
Malignant hepatic tumors in pediatric patients: clinical and radiological features WCRJ 2015; 2 (1): e481
Study of epigenetic alteration of the promoter region of p16, BRCA1, GSTP1 genes and sporadic breast cancer WCRJ 2015; 2 (1): e479
Pre-operative chemotherapy for colorectal cancer with liver metastases and conversion therapy WCRJ 2015; 2 (1): e473